Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2040563590', 'doi': 'https://doi.org/10.1002/ddr.20121', 'title': 'Therapeutic applications of incretin mimetics for metabolic diseases: preclinical studies', 'display_name': 'Therapeutic applications of incretin mimetics for metabolic diseases: preclinical studies', 'publication_year': 2006, 'publication_date': '2006-07-01', 'ids': {'openalex': 'https://openalex.org/W2040563590', 'doi': 'https://doi.org/10.1002/ddr.20121', 'mag': '2040563590'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/ddr.20121', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S26306840', 'display_name': 'Drug Development Research', 'issn_l': '0272-4391', 'issn': ['0272-4391', '1098-2299'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5003861918', 'display_name': 'Christine M. Mack', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christine Mack', 'raw_affiliation_strings': ['Amylin Pharmaceuticals, Inc., San Diego, California'], 'affiliations': [{'raw_affiliation_string': 'Amylin Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037242913', 'display_name': 'Kevin D. Laugero', 'orcid': 'https://orcid.org/0000-0003-2775-0728'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kevin Laugero', 'raw_affiliation_strings': ['Amylin Pharmaceuticals, Inc., San Diego, California'], 'affiliations': [{'raw_affiliation_string': 'Amylin Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017690868', 'display_name': 'Que Liu', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Que Liu', 'raw_affiliation_strings': ['Amylin Pharmaceuticals, Inc., San Diego, California'], 'affiliations': [{'raw_affiliation_string': 'Amylin Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5068297947', 'display_name': 'Carolyn M. Jodka', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Carolyn Jodka', 'raw_affiliation_strings': ['Amylin Pharmaceuticals, Inc., San Diego, California'], 'affiliations': [{'raw_affiliation_string': 'Amylin Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101566054', 'display_name': 'Andrew Young', 'orcid': 'https://orcid.org/0000-0002-9751-9241'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrew Young', 'raw_affiliation_strings': ['Amylin Pharmaceuticals, Inc., San Diego, California'], 'affiliations': [{'raw_affiliation_string': 'Amylin Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5077809872', 'display_name': 'David G. Parkes', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David Parkes', 'raw_affiliation_strings': ['Amylin Pharmaceuticals, Inc., San Diego, California'], 'affiliations': [{'raw_affiliation_string': 'Amylin Pharmaceuticals, Inc., San Diego, California', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3610, 'currency': 'USD', 'value_usd': 3610, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.579, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.599744, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 72, 'max': 74}, 'biblio': {'volume': '67', 'issue': '7', 'first_page': '553', 'last_page': '558'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10839', 'display_name': 'Pancreatic function and diabetes', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11339', 'display_name': 'Metabolism, Diabetes, and Cancer', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/incretin', 'display_name': 'Incretin', 'score': 0.9101813}], 'concepts': [{'id': 'https://openalex.org/C2780533449', 'wikidata': 'https://www.wikidata.org/wiki/Q417762', 'display_name': 'Exenatide', 'level': 4, 'score': 0.98107064}, {'id': 'https://openalex.org/C2778881409', 'wikidata': 'https://www.wikidata.org/wiki/Q1420402', 'display_name': 'Incretin', 'level': 4, 'score': 0.9101813}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6520346}, {'id': 'https://openalex.org/C511355011', 'wikidata': 'https://www.wikidata.org/wiki/Q12174', 'display_name': 'Obesity', 'level': 2, 'score': 0.4750942}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.46975043}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4606706}, {'id': 'https://openalex.org/C2780578515', 'wikidata': 'https://www.wikidata.org/wiki/Q657193', 'display_name': 'Metabolic syndrome', 'level': 3, 'score': 0.44142962}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.43085253}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.41756347}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.41292012}, {'id': 'https://openalex.org/C60644358', 'wikidata': 'https://www.wikidata.org/wiki/Q128570', 'display_name': 'Bioinformatics', 'level': 1, 'score': 0.32096142}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.1799224}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/ddr.20121', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S26306840', 'display_name': 'Drug Development Research', 'issn_l': '0272-4391', 'issn': ['0272-4391', '1098-2299'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 24, 'referenced_works': ['https://openalex.org/W1507814807', 'https://openalex.org/W1508456959', 'https://openalex.org/W1831731874', 'https://openalex.org/W1950017428', 'https://openalex.org/W1968315455', 'https://openalex.org/W1983901940', 'https://openalex.org/W1984740259', 'https://openalex.org/W1986085856', 'https://openalex.org/W1993072922', 'https://openalex.org/W2013082477', 'https://openalex.org/W2013665956', 'https://openalex.org/W2028515800', 'https://openalex.org/W2056765268', 'https://openalex.org/W2063105888', 'https://openalex.org/W2063400466', 'https://openalex.org/W2064918884', 'https://openalex.org/W2065867087', 'https://openalex.org/W2109327370', 'https://openalex.org/W2116552304', 'https://openalex.org/W2124687416', 'https://openalex.org/W2124831863', 'https://openalex.org/W2154433442', 'https://openalex.org/W2162934281', 'https://openalex.org/W2171174384'], 'related_works': ['https://openalex.org/W4361286763', 'https://openalex.org/W2610552735', 'https://openalex.org/W2411384485', 'https://openalex.org/W2189420872', 'https://openalex.org/W2171424789', 'https://openalex.org/W2161407981', 'https://openalex.org/W2100816243', 'https://openalex.org/W2064365715', 'https://openalex.org/W2052719689', 'https://openalex.org/W1945989183'], 'abstract_inverted_index': {'Abstract': [0], 'Exenatide': [1], '(exendin‐4)': [2], 'is': [3], 'an': [4], 'incretin': [5, 16], 'mimetic': [6], 'peptide': [7], 'that': [8], 'shares': [9], 'several': [10], 'glucoregulatory': [11], 'actions': [12, 22], 'with': [13, 74], 'the': [14, 60], 'endogenous': [15], 'GLP‐1.': [17], 'In': [18], 'addition': [19], 'to': [20, 29, 47, 76], 'its': [21, 66], 'on': [23, 72], 'glucose': [24], 'control,': [25], 'exenatide': [26, 42, 64], 'produces': [27], 'effects': [28, 62], 'reduce': [30], 'food': [31], 'intake': [32], 'and': [33, 41, 54, 69, 79, 90], 'body': [34], 'weight': [35], 'in': [36, 51, 82], 'all': [37], 'species': [38], 'studied.': [39], 'GLP‐1': [40], 'have': [43], 'also': [44], 'been': [45], 'shown': [46], 'modulate': [48], 'cardiovascular': [49], 'function': [50], 'both': [52], 'animal': [53], 'human': [55], 'studies.': [56], 'This': [57], 'overview': [58], 'examines': [59], 'metabolic': [61, 88], 'of': [63, 85], 'beyond': [65], 'antidiabetic': [67], 'actions,': [68], 'will': [70], 'focus': [71], 'studies': [73], 'respect': [75], 'obesity,': [77, 87], 'hypertension,': [78], 'cardiac': [80], 'dysfunction': [81], 'preclinical': [83], 'models': [84], 'diet‐induced': [86], 'syndrome,': [89], 'chronic': [91], 'heart': [92], 'failure': [93], '.': [94], 'Drug': [95], 'Dev.': [96], 'Res.': [97], '67:553–558,': [98], '2006.©': [99], '2006': [100], 'Wiley‐Liss,': [101], 'Inc.': [102]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2040563590', 'counts_by_year': [], 'updated_date': '2024-12-08T09:12:57.056817', 'created_date': '2016-06-24'}